Search research articles
Contact Us
Filters
Showing results (361-370 of 467) with videos related to
Page
of 47
Sort By:
Basic Research in Cardiology
|
September 4, 2020
Interruption of vascular endothelial growth factor receptor 2 signaling induces a proliferative pulmonary vasculopathy and pulmonary hypertension
Max-Paul Winter, Smriti Sharma, Johanna Altmann, et al.
Journal for Immunotherapy of Cancer
|
March 25, 2021
Tumor DNA methylation profiles correlate with response to anti-PD-1 immune checkpoint inhibitor monotherapy in sarcoma patients
Angelika M Starzer, Anna S Berghoff, Rainer Hamacher, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 10, 2023
Theranostics in Neurooncology: Heading Toward New Horizons
Nelleke Tolboom, Antoine Verger, Nathalie L Albert, et al.
Clinical Neurology and Neurosurgery
|
August 3, 2021
Frequency of actionable molecular drivers in lung cancer patients with precocious brain metastases
Benjamin Hanke, Stephanie T Jünger, Elmar Kirches, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 30, 2023
Zotiraciclib (TG02) for newly diagnosed glioblastoma in the elderly or for recurrent glioblastoma: The EORTC 1608 STEAM trial
Emilie Le Rhun, Thierry Gorlia, Jörg Felsberg, et al.
Neuro-Oncology
|
February 11, 2026
The prognostic impact of CDKN2A/B hemizygous deletions in meningioma
Franziska M Ippen, Thomas Hielscher, Areeba Patel, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 27, 2024
Addressing the role of surgery in brain tumour trials: A report from the neurosurgery committee of the EORTC brain tumour group
Johnny Duerinck, Philipp Karschnia, Marike Broekman, et al.
Future Oncology (London, England)
|
February 28, 2025
TUXEDO-4: phase II study of trastuzumab-deruxtecan in HER2-low breast cancer with new or progressing brain metastases
Maximilian Marhold, Marta Vaz Batista, Isabel Blancas, et al.
Neuro-Oncology
|
August 24, 2018
Proposed response assessment and endpoints for meningioma clinical trials: report from the Response Assessment in Neuro-Oncology Working Group
Raymond Y Huang, Wenya Linda Bi, Michael Weller, et al.
Neuro-Oncology Advances
|
July 10, 2020
Bevacizumab-based treatment as salvage therapy in patients with recurrent symptomatic brain metastases
Anna Sophie Berghoff, Michael Oliver Breckwoldt, Lars Riedemann, et al.
Page
of 47
Search research articles
Search
Showing results (361-370 of 467) with videos related to
Sort By:
Page
of 47
Basic Research in Cardiology
|
September 4, 2020
Interruption of vascular endothelial growth factor receptor 2 signaling induces a proliferative pulmonary vasculopathy and pulmonary hypertension
Max-Paul Winter, Smriti Sharma, Johanna Altmann, et al.
Journal for Immunotherapy of Cancer
|
March 25, 2021
Tumor DNA methylation profiles correlate with response to anti-PD-1 immune checkpoint inhibitor monotherapy in sarcoma patients
Angelika M Starzer, Anna S Berghoff, Rainer Hamacher, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 10, 2023
Theranostics in Neurooncology: Heading Toward New Horizons
Nelleke Tolboom, Antoine Verger, Nathalie L Albert, et al.
Clinical Neurology and Neurosurgery
|
August 3, 2021
Frequency of actionable molecular drivers in lung cancer patients with precocious brain metastases
Benjamin Hanke, Stephanie T Jünger, Elmar Kirches, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 30, 2023
Zotiraciclib (TG02) for newly diagnosed glioblastoma in the elderly or for recurrent glioblastoma: The EORTC 1608 STEAM trial
Emilie Le Rhun, Thierry Gorlia, Jörg Felsberg, et al.
Neuro-Oncology
|
February 11, 2026
The prognostic impact of CDKN2A/B hemizygous deletions in meningioma
Franziska M Ippen, Thomas Hielscher, Areeba Patel, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 27, 2024
Addressing the role of surgery in brain tumour trials: A report from the neurosurgery committee of the EORTC brain tumour group
Johnny Duerinck, Philipp Karschnia, Marike Broekman, et al.
Future Oncology (London, England)
|
February 28, 2025
TUXEDO-4: phase II study of trastuzumab-deruxtecan in HER2-low breast cancer with new or progressing brain metastases
Maximilian Marhold, Marta Vaz Batista, Isabel Blancas, et al.
Neuro-Oncology
|
August 24, 2018
Proposed response assessment and endpoints for meningioma clinical trials: report from the Response Assessment in Neuro-Oncology Working Group
Raymond Y Huang, Wenya Linda Bi, Michael Weller, et al.
Neuro-Oncology Advances
|
July 10, 2020
Bevacizumab-based treatment as salvage therapy in patients with recurrent symptomatic brain metastases
Anna Sophie Berghoff, Michael Oliver Breckwoldt, Lars Riedemann, et al.
Page
of 47